Kaplan–Meier survival analysis indicated that patients with HCC who displayed high WASF2 expression had significantly lower 5-year OS and DFS rates than those with low WASF2 expression (OS, log-rank p < 0.0001, hazard ratio [HR] = 2.31; DFS, log-rank p < 0.0001, HR = 1.97; Fig. S3B). Here, WASF2 is linked to hepatocellular carcinoma.